about
Multiple risk factor interventions for primary prevention of coronary heart diseaseMultiple risk factor interventions for primary prevention of coronary heart diseaseDisease impact number and population impact number: population perspectives to measures of risk and benefitCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsAspirin use for the prevention of cardiovascular disease: the British Women's Heart and Health StudyIssues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomesThe number needed to treat: a clinically useful measure of treatment effectUsing group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence.Getting research findings into practice. When to act on the evidence.Tackling health inequalities in primary care. Exploring possible solutions to a problem is more important than describing the problem.Multiple risk factor interventions for primary prevention of coronary heart disease.Three-armed trials including placebo and no-treatment groups may be subject to publication bias: systematic review.Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis.Patients' responses to risk information about the benefits of treating hypertension.Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.Applying the results of clinical trials to patients to general practice: perceived problems, strengths, assumptions, and challenges for the future.Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence.Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits.The relation between questions indicating transient ischaemic attack and stroke in 20 years of follow up in men and women in the Renfrew/Paisley Study.Meta-analysis: Can we mix apples and oranges?What constitutes controlled hypertension? Patient based comparison of hypertension guidelines.Coronary artery bypass surgery in smokers.Cigarette smoking in British men and selection for coronary artery bypass surgery.Statistical problemsExplaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches.The relation between treatment benefit and underlying risk in meta-analysis.Clinical relevance of about-yearly changes in blood pressure and the environment.EUR-ASSESS Project Subgroup report on Methodology. Methodological guidance for the conduct of health technology assessment.An evidence based approach to individualising treatment.Knowledge of cardiothoracic ratio adds to cardiovascular risk stratification.The aspirin papers.Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.Evaluation of the electrodiagnostic investigation of children using the Greenwich Grading System.Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk?
P2860
Q24234642-DB76AC97-EA21-4139-847C-DC1DFFC9E309Q24243941-114A7297-7282-4D19-AA26-9A0BB76132BBQ24524813-4D8E6545-87C5-4465-84B7-F76BE08C20D2Q24614627-410AABF3-080E-4AC4-B838-959DBF589501Q28189982-F1F58DE6-D1E9-43CF-94FF-850A0729A5D6Q28193390-07096DB4-4AFD-49EF-803C-861FCEFFBB54Q29619672-5BD80447-C8F6-4BF3-8B6D-01BFD1AE1B61Q31143342-F2AE12FA-4EDA-400A-BA51-EF438C78CFDDQ33790985-B86A5A01-FD73-44A1-BEDE-8F6CCD3A5CFAQ33816485-1E944738-EB0E-4BDB-8DC3-B7177610A1BBQ33909905-97173EC0-6F4C-40EF-8C94-DCE1F73C0320Q33926962-BC7E6ABE-6417-487B-A5C8-84D02C8B5E30Q34137437-6E13477F-0B5F-418A-AA94-E09C68271746Q34220002-A760C338-533A-4EC7-977A-BF4B5BCD15C6Q34307827-59BBF5C0-20E9-47BE-904D-4497259F0368Q34469512-839ED1D9-AB30-435D-9DD4-9F83BAF29622Q34652920-C67EFFC6-9DD3-465B-AAD7-1240D26CAD50Q34712222-BD74EEBB-4080-4BC4-A2F2-DBFF599AC02DQ35406197-DF5AA8DE-CE40-4F99-8356-9C5C7B20B742Q35967468-CA2B588B-0B85-4CD1-B978-C5AC5576053FQ36599250-E4B9354E-8290-481A-958B-3F706BD381AEQ36832195-85CF42A0-4F8C-4730-8FDD-EC239C4C4ED0Q36832290-DCC8BFF6-2C8F-43D1-9BBC-A00166EE2C2FQ36885016-ADD51B0C-D2A9-4334-9CE3-065B3ED484BFQ36929025-AA4B6666-116A-4796-B397-8D3FB49D39A9Q39453386-2869D2ED-EDBA-4939-BBD4-0165158FB4E0Q41329353-28CF7395-C04E-4CC5-AD12-AF7BA19E4CFCQ41508198-C876C0B8-9BEB-440D-995B-239EB2AF18F8Q41849533-91D9ADC2-C792-46AC-BC08-839046BC1111Q42116240-ACCB769D-850A-4DA1-9D7C-F2B645C4BC6AQ42560177-B3D7A52B-DED1-4AF0-9A43-22F8B5E5BC1CQ44059947-EA930A9D-E94C-4F69-8BAB-00E031E12915Q44715681-B8F8DFD1-601A-439A-A957-BF02EF4E7BDCQ57745957-2C60D29E-EF00-4800-BA23-4AFC843464DA
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Who benefits from medical interventions?
@en
Who benefits from medical interventions?
@nl
type
label
Who benefits from medical interventions?
@en
Who benefits from medical interventions?
@nl
prefLabel
Who benefits from medical interventions?
@en
Who benefits from medical interventions?
@nl
P2860
P356
P1433
P1476
Who benefits from medical interventions?
@en
P2093
P2860
P356
10.1136/BMJ.308.6921.72
P407
P577
1994-01-01T00:00:00Z